| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2001PNAS...98.4587S |
| P356 | DOI | 10.1073/PNAS.071063898 |
| P8608 | Fatcat ID | release_ek5b4igcmrh5bhnir5nq2v6dgm |
| P932 | PMC publication ID | 31878 |
| P698 | PubMed publication ID | 11287644 |
| P5875 | ResearchGate publication ID | 12045595 |
| P50 | author | Peter C. Doherty | Q309814 |
| Julia L. Hurwitz | Q97727006 | ||
| P2093 | author name string | S W White | |
| B Jones | |||
| J M Riberdy | |||
| K S Slobod | |||
| S Surman | |||
| T D Lockey | |||
| P2860 | cites work | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 |
| Viral immune evasion due to persistence of activated T cells without effector function | Q24646943 | ||
| MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 | ||
| Raster3D: photorealistic molecular graphics | Q27860557 | ||
| Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
| The antigenic structure of the HIV gp120 envelope glycoprotein | Q28274698 | ||
| Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response | Q28282853 | ||
| Get into the groove! Targeting antigens to MHC class II. | Q33815384 | ||
| The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation | Q33815394 | ||
| Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting | Q33815419 | ||
| Mechanisms and consequences of peptide selection by the I-Ak class II molecule | Q33815430 | ||
| Peptide exchange in MHC molecules | Q33815435 | ||
| Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands | Q33930607 | ||
| An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. | Q34485526 | ||
| CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection | Q35873254 | ||
| Roles of alpha beta and gamma delta T cell subsets in viral immunity | Q35876930 | ||
| CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma | Q36338436 | ||
| Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition | Q36344766 | ||
| The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype | Q36349414 | ||
| Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies | Q36620408 | ||
| CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
| Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies | Q36884458 | ||
| Polyadenylylation of sea urchin histone RNA sequences in transfected COS cells | Q37678089 | ||
| HIV type 1 envelope sequence diversity in inner city community | Q39392294 | ||
| Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting | Q39397356 | ||
| MHC ligands and peptide motifs: first listing | Q40612811 | ||
| A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation | Q40818252 | ||
| Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients | Q41338390 | ||
| MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. | Q41467916 | ||
| The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses | Q41870329 | ||
| Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. | Q42611420 | ||
| T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region. | Q42991684 | ||
| High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment | Q42998082 | ||
| A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans | Q43420730 | ||
| Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus | Q43817319 | ||
| LacZ inducible, antigen/MHC-specific T cell hybrids | Q44031720 | ||
| The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift | Q45147766 | ||
| Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants | Q45763280 | ||
| Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. | Q45787219 | ||
| Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice | Q45788824 | ||
| T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction | Q45846878 | ||
| CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice | Q45860713 | ||
| Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
| Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies | Q48042932 | ||
| Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals? | Q48070843 | ||
| Two better cell lines for making hybridomas expressing specific T cell receptors. | Q48287125 | ||
| Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals. | Q52372500 | ||
| Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
| Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1 | Q55241675 | ||
| HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. | Q55242365 | ||
| HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization | Q56921434 | ||
| HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains | Q58415406 | ||
| Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans | Q59046097 | ||
| Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein | Q67699031 | ||
| Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells | Q68083664 | ||
| Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells | Q69909322 | ||
| Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides | Q77320371 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4587-4592 | |
| P577 | publication date | 2001-04-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing | |
| P478 | volume | 98 |
| Q28389250 | A Multi-Vector, Multi-Envelope HIV-1 Vaccine |
| Q34492984 | A closer look at proteolysis and MHC-class-II-restricted antigen presentation. |
| Q43712997 | A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty? |
| Q77492279 | A highly sensitive single-cell assay detects T-helper cell responses missed by conventional interleukin-2-based methods |
| Q36315473 | A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein |
| Q27481378 | A systematic bioinformatics approach for selection of epitope-based vaccine targets |
| Q45735715 | Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120. |
| Q34057942 | Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial |
| Q37373708 | Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. |
| Q36687906 | Bioinformatics for study of autoimmunity |
| Q84957632 | CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection |
| Q30384608 | CD4+ T-cell epitope prediction using antigen processing constraints |
| Q34100215 | Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin |
| Q79125450 | Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity |
| Q33582318 | Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire |
| Q36371928 | Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells |
| Q34059460 | Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein |
| Q37422520 | Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides |
| Q41360867 | Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions |
| Q41078346 | Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120. |
| Q24288762 | Conservation and variability of dengue virus proteins: implications for vaccine design |
| Q34717906 | Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen |
| Q36473515 | Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4 |
| Q33883887 | Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 |
| Q80966875 | Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins |
| Q95323134 | Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help |
| Q28394899 | Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials |
| Q33322206 | Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes |
| Q29307502 | Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope |
| Q35122914 | Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing |
| Q34128586 | Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein |
| Q45421005 | Immunogenicity of calreticulin-bound murine leukemia virus glycoprotein gp90. |
| Q33725711 | Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120 |
| Q34781685 | Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein |
| Q55877037 | Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy |
| Q42729706 | MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles |
| Q47549431 | Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome |
| Q47993951 | Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells |
| Q87163708 | Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol |
| Q44189653 | Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV. |
| Q36475897 | Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins |
| Q92093979 | Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin |
| Q28611993 | Presentation of antigens by MHC class II molecules: getting the most out of them |
| Q24645308 | Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes |
| Q56893551 | Respiratory syncytial virus vaccine development |
| Q40334895 | SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens |
| Q40459706 | Short Communication: Parallel Analyses of Systemic and Local Vaccinations with Envelope Formulated in Adjuvant for Induction of HIV-Specific Antibodies in the Vaginal Mucosa. |
| Q34477154 | Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid |
| Q33900413 | Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction |
| Q55084358 | Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection. |
| Q42648564 | T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry |
| Q28383908 | Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities |
| Q39422790 | The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine |
| Q36424504 | The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers |
| Q42947548 | Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models |
| Q30414377 | UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV. |
| Q40935197 | Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells |
| Q35166856 | WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies |
| Q33916280 | Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response |
Search more.